Global Cancer Stem Cell Industry
New Study On “2018-2025 Cancer Stem Cell Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
This report focuses on the global Cancer Stem Cell status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Stem Cell development in United States, Europe and China.
Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.
North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.
Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.
In 2017, the global Cancer Stem Cell market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Thermo Fisher Scientific, Inc.
Stemline Therapeutics, Inc.
OncoMed Pharmaceuticals, Inc.
STEMCELL Technologies Inc.
Sino Biological Inc.
Market segment by Type, the product can be split into
Market segment by Application, split into
Stem Cell Based Cancer Therapy
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Cancer Stem Cell status, future forecast, growth opportunity, key market and key players.
To present the Cancer Stem Cell development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3351308-global-cancer-stem-cell-market-size-status-and-forecast-2018-2025
Some Major Points from Table of content:
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Stem Cell Market Size Growth Rate by Type (2013-2025)
1.4.2 Cell Culturing
1.4.3 Cell Separation
1.4.4 Cell Analysis
1.4.5 Molecular Analysis
1.5 Market by Application
1.5.1 Global Cancer Stem Cell Market Share by Application (2013-2025)
1.5.2 Stem Cell Based Cancer Therapy
1.5.3 Targeted CSCs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Stem Cell Market Size
2.2 Cancer Stem Cell Growth Trends by Regions
2.2.1 Cancer Stem Cell Market Size by Regions (2013-2025)
2.2.2 Cancer Stem Cell Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Stem Cell Market Size by Manufacturers
3.1.1 Global Cancer Stem Cell Revenue by Manufacturers (2013-2018)
3.1.2 Global Cancer Stem Cell Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Stem Cell Key Players Head office and Area Served
3.3 Key Players Cancer Stem Cell Product/Solution/Service
3.4 Date of Enter into Cancer Stem Cell Market
3.5 Mergers & Acquisitions, Expansion Plans
12 International Players Profiles
12.1 Thermo Fisher Scientific, Inc.
12.1.1 Thermo Fisher Scientific, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Stem Cell Introduction
12.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
12.1.5 Thermo Fisher Scientific, Inc. Recent Development
12.2 AbbVie, Inc.
12.2.1 AbbVie, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Stem Cell Introduction
12.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
12.2.5 AbbVie, Inc. Recent Development
12.3 Merck KGaA
12.3.1 Merck KGaA Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Stem Cell Introduction
12.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2013-2018)
12.3.5 Merck KGaA Recent Development
12.4.1 Bionomics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Stem Cell Introduction
12.4.4 Bionomics Revenue in Cancer Stem Cell Business (2013-2018)
12.4.5 Bionomics Recent Development
12.5.1 Lonza Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Stem Cell Introduction
12.5.4 Lonza Revenue in Cancer Stem Cell Business (2013-2018)
12.5.5 Lonza Recent Development
12.6 Stemline Therapeutics, Inc.
12.6.1 Stemline Therapeutics, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Stem Cell Introduction
12.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
12.6.5 Stemline Therapeutics, Inc. Recent Development
12.7 Miltenyi Biotec
12.7.1 Miltenyi Biotec Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Stem Cell Introduction
12.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2013-2018)
12.7.5 Miltenyi Biotec Recent Development
12.8 PromoCell GmbH
12.8.1 PromoCell GmbH Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Stem Cell Introduction
12.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2013-2018)
12.8.5 PromoCell GmbH Recent Development
12.9 MacroGenics, Inc.
12.9.1 MacroGenics, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Stem Cell Introduction
12.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
12.9.5 MacroGenics, Inc. Recent Development
12.10 OncoMed Pharmaceuticals, Inc.
12.10.1 OncoMed Pharmaceuticals, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Stem Cell Introduction
12.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
12.10.5 OncoMed Pharmaceuticals, Inc. Recent Development
12.11 Irvine Scientific
12.12 STEMCELL Technologies Inc.
12.13 Sino Biological Inc.
12.14 BIOTIME, Inc.
For more information or any query mail at [email protected]
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym